$Outcomes of second allogeneic stem cell transplantation and anti‐relapse strategies in patients with relapsed/refractory acute myeloid leukemia: A unicentric retrospective analysis$

Outcomes of second allogeneic stem cell transplantation and anti‐relapse strategies in patients with relapsed/refractory acute myeloid leukemia: A unicentric retrospective analysis

Second allogeneic stem cell transplantation (allo‐SCT2) represents a rescue option for selected patients (pts) with relapsed/refractory (r/r) acute myeloid leukemia (AML). Still, relapse rates post‐allo‐SCT2 remain high and effective anti‐relapse strategies and predictive biomarkers remain to be def...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hematological oncology 2022-10, Vol.40 (4), p.763-776
Hauptverfasser:	Shumilov, Evgenii, Hasenkamp, Justin, Maulhardt, Markus, Mazzeo, Paolo, Schmidt, Nicole, Boyadzhiev, Hristo, Jung, Wolfram, Ganster, Christina, Haase, Detlef, Koch, Raphael, Wulf, Gerald
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute myeloid leukemia anti‐relapse strategies beyond allo‐SCT2 Azacytidine Biomarkers Chemotherapy Cytogenetics donor lymphocyte infusion (DLI) Leukemia Lymphocytes relapsed/refractory acute myeloid leukemia (r/r AML) Remission Remission (Medicine) second allogeneic stem cell transplantation (allo‐SCT2) Stem cell transplantation Stem cells Transplantation venetoclax
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!